X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2846) 2846
Publication (369) 369
Book Review (17) 17
Book Chapter (14) 14
Dissertation (11) 11
Conference Proceeding (10) 10
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1808) 1808
male (1464) 1464
rats (1170) 1170
neurosciences (1153) 1153
serotonin (1078) 1078
pharmacology & pharmacy (1044) 1044
index medicus (1021) 1021
humans (843) 843
receptor, serotonin, 5-ht2a - metabolism (716) 716
serotonin antagonists - pharmacology (704) 704
5-ht (634) 634
receptor, serotonin, 5-ht2a (597) 597
5-ht2a receptor (570) 570
psychiatry (538) 538
rats, sprague-dawley (509) 509
mice (503) 503
female (502) 502
dose-response relationship, drug (480) 480
serotonin receptor agonists - pharmacology (444) 444
receptors, serotonin - drug effects (409) 409
receptors, serotonin - metabolism (379) 379
schizophrenia (368) 368
rats, wistar (344) 344
5-ht2a receptors (340) 340
receptor (338) 338
receptors (330) 330
serotonin - metabolism (316) 316
brain (299) 299
5-ht2a (289) 289
adult (255) 255
ketanserin - pharmacology (253) 253
serotonin receptors (248) 248
dopamine (238) 238
rat (236) 236
receptor, serotonin, 5-ht2a - genetics (233) 233
brain - metabolism (232) 232
antagonist (223) 223
prefrontal cortex (223) 223
serotonin - pharmacology (223) 223
piperidines - pharmacology (219) 219
antipsychotic agents - pharmacology (213) 213
receptor, serotonin, 5-ht2a - drug effects (211) 211
5-hydroxytryptamine (210) 210
behavior, animal - drug effects (210) 210
receptors, serotonin - physiology (206) 206
amphetamines - pharmacology (204) 204
receptor, serotonin, 5-ht2a - physiology (198) 198
piperazines - pharmacology (196) 196
clinical neurology (195) 195
article (193) 193
binding (189) 189
biochemistry & molecular biology (181) 181
chemistry, medicinal (179) 179
fluorobenzenes - pharmacology (175) 175
serotonin 5-ht2 receptor antagonists (175) 175
in-vivo (174) 174
ligands (165) 165
activation (164) 164
pharmacology (164) 164
antagonists (162) 162
rat-brain (162) 162
brain - drug effects (161) 161
in vitro techniques (160) 160
middle aged (158) 158
disease models, animal (156) 156
time factors (152) 152
biomedicine (150) 150
neurons (148) 148
serotonin 5-ht2 receptor antagonists - pharmacology (148) 148
structure-activity relationship (146) 146
analysis (145) 145
motor activity - drug effects (144) 144
behavioral sciences (140) 140
ketanserin (138) 138
depression (137) 137
receptor, serotonin, 5-ht1a - metabolism (137) 137
clozapine (135) 135
serotonin s2 receptors (131) 131
medial prefrontal cortex (129) 129
receptor, serotonin, 5-ht2c (129) 129
pharmacology/toxicology (123) 123
rodents (122) 122
drugs (120) 120
mice, inbred c57bl (119) 119
phenols (116) 116
radioligand assay (116) 116
neurology (112) 112
expression (111) 111
receptor, serotonin, 5-ht2c - metabolism (111) 111
hallucinogens - pharmacology (110) 110
analysis of variance (109) 109
indoles - pharmacology (109) 109
positron-emission-tomography (108) 108
frontal-cortex (107) 107
messenger-rna (107) 107
nucleus-accumbens (107) 107
neurons - drug effects (106) 106
serotonin - physiology (106) 106
agonist (105) 105
prefrontal cortex - drug effects (105) 105
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2825) 2825
Japanese (41) 41
Russian (11) 11
German (9) 9
French (6) 6
Chinese (5) 5
Spanish (3) 3
Portuguese (2) 2
Czech (1) 1
Serbian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


NeuroImage, ISSN 1053-8119, 04/2016, Volume 130, pp. 167 - 174
[11C]Cimbi-36 is a recently developed serotonin 2A (5-HT2A) receptor agonist positron emission tomography (PET) radioligand that has been successfully applied... 
Neuroimaging | Agonist | 5-HT | Positron emission tomography | Radiotracer evaluation | Test–retest variability | Test-retest variability | SURFACE-BASED ANALYSIS | SYSTEM | LOCALIZATION | RADIOLIGAND | QUANTIFICATION | 5-HT2A RECEPTOR | NEUROSCIENCES | POSITRON-EMISSION-TOMOGRAPHY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET | Serotonin 5-HT2 Receptor Agonists - pharmacokinetics | Humans | Ketanserin - analogs & derivatives | Male | Benzylamines - metabolism | Brain - metabolism | Young Adult | Radiopharmaceuticals - metabolism | Fluorine Radioisotopes - pharmacokinetics | Phenethylamines - pharmacokinetics | Female | Serotonin 5-HT2 Receptor Agonists - metabolism | Neuroimaging - methods | Reproducibility of Results | Radiopharmaceuticals - pharmacokinetics | Carbon Radioisotopes - pharmacokinetics | Phenethylamines - metabolism | Positron-Emission Tomography - methods | Serotonin 5-HT2 Receptor Antagonists - pharmacokinetics | Ketanserin - metabolism | Ketanserin - pharmacokinetics | Serotonin 5-HT2 Receptor Antagonists - metabolism | Fluorine Radioisotopes - metabolism | Carbon Radioisotopes - metabolism | Benzylamines - pharmacokinetics | Phenols | Brain | Serotonin | Analysis | Choroid plexus | Medical imaging | Lysergic acid diethylamide--LSD | Cortex | Radioisotopes | Serotonin S2 receptors | Tomography | Receptor density | Agonists | Hippocampus
Journal Article
Pharmacology, Biochemistry and Behavior, ISSN 0091-3057, 06/2019, Volume 181, pp. 37 - 45
Journal Article
ACS Chemical Neuroscience, ISSN 1948-7193, 08/2012, Volume 4, Issue 1, pp. 110 - 121
Journal Article
Journal Article
Psychopharmacology, ISSN 0033-3158, 1/2014, Volume 231, Issue 1, pp. 269 - 281
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, p. e0159776
Purpose To assess the neuroprotective effects of flibanserin (formerly BIMT-17), a dual 5-HT1A agonist and 5-HT2A antagonist, in a light-induced retinopathy... 
PHOTORECEPTOR CELL-DEATH | GREEN FLUORESCENT PROTEIN | OXIDATIVE STRESS | SEXUAL DESIRE DISORDER | ADENOVIRUS-MEDIATED DELIVERY | OPTICAL COHERENCE TOMOGRAPHY | RABBIT RETINA | MULTIDISCIPLINARY SCIENCES | PREMENOPAUSAL WOMEN EFFICACY | LIGHT-INDUCED RETINOPATHY | LEBERS CONGENITAL AMAUROSIS | Retina - drug effects | Retina - metabolism | Receptor, Serotonin, 5-HT2A - genetics | Apoptosis - drug effects | Apoptosis - radiation effects | Receptor, Serotonin, 5-HT1A - genetics | Cell Survival - genetics | Apoptosis - genetics | Male | Retinal Diseases - metabolism | Antioxidants | Neuroprotective Agents - pharmacology | Retinal Diseases - etiology | Receptor, Serotonin, 5-HT1A - metabolism | Electroretinography | Retina - radiation effects | Cell Survival - drug effects | Retinal Diseases - diagnosis | Tomography, Optical Coherence | Light - adverse effects | Gene Knockout Techniques | Cell Survival - radiation effects | Animals | Serotonin Agents - pharmacology | Benzimidazoles - pharmacology | Mice | Retinal Diseases - drug therapy | Receptor, Serotonin, 5-HT2A - metabolism | Dose-Response Relationship, Radiation | Retina - pathology | Genetically modified mice | Care and treatment | Usage | Retinal degeneration | Research | Diagnosis | Gene expression | Neuroprotection | Oxidative stress | Transcription factors | Retinopathy | Bcl-2 protein | Science | Retina | Superoxide dismutase | Serotonin S1 receptors | Receptors | Mitochondria | Fos protein | Rodents | Light | Localization | c-Fos protein | Serotonin | Albinism | c-Jun protein | Federal regulation | Exposure | FDA approval | Serotonin S2 receptors | Cyclic AMP response element-binding protein | Luminous intensity | Optical Coherence Tomography | Photoreceptors | Apoptosis | Structure-function relationships
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 02/2001, Volume 44, Issue 4, pp. 477 - 501
ATYPICAL ANTIPSYCHOTIC-DRUGS | IN-VIVO MICRODIALYSIS | CHEMISTRY, MEDICINAL | NITRIC-OXIDE SYNTHASE | POSITRON EMISSION TOMOGRAPHY | HIGH-AFFINITY ANTAGONIST | METABOTROPIC GLUTAMATE RECEPTORS | CENTRAL-NERVOUS-SYSTEM | EXCITOTOXIC HIPPOCAMPAL DAMAGE | DOPAMINE D-4 RECEPTOR | D-ASPARTATE RECEPTOR | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | Excitatory Amino Acid Antagonists - therapeutic use | Schizophrenia - metabolism | Antipsychotic Agents - adverse effects | Humans | Receptors, Serotonin - drug effects | Nitric Oxide Synthase - antagonists & inhibitors | Cholinergic Agonists - therapeutic use | Cholinergic Agonists - adverse effects | Serotonin Antagonists - adverse effects | Antipsychotic Agents - therapeutic use | Receptors, Dopamine D2 - drug effects | Excitatory Amino Acid Antagonists - adverse effects | Cholinergic Agonists - pharmacology | Disease Models, Animal | Enzyme Inhibitors - adverse effects | Enzyme Inhibitors - pharmacology | Serotonin Antagonists - therapeutic use | Dopamine Antagonists - therapeutic use | Mice, Transgenic | Excitatory Amino Acid Antagonists - pharmacology | Serotonin Antagonists - pharmacology | Enzyme Inhibitors - therapeutic use | Receptor, Serotonin, 5-HT2A | Schizophrenia - etiology | Receptors, Neurotensin - agonists | Animals | Dopamine Antagonists - pharmacology | Receptors, Dopamine D4 | Dopamine Antagonists - adverse effects | Mice | Antipsychotic Agents - pharmacology | Schizophrenia - drug therapy | Receptors, Metabotropic Glutamate - antagonists & inhibitors | Receptors, AMPA - antagonists & inhibitors
Journal Article